Fatal Adverse Events Associated With Programmed Cell Death Ligand 1 Inhibitors: A Systematic Review and Meta-Analysis

Lignende værker

• Fatal adverse events associated with programmed cell death protein 1 or programmed cell death-ligand 1 monotherapy in cancer
  af: Zhao, Bin, et al.
  Udgivet: (2020)
• Construction of predictive model for programmed death-1 inhibitor-related endocrine adverse events
  af: Jiaying SHI, et al.
  Udgivet: (2025-08-01)
• Adverse cardiac events in the treatment of non-small cell lung cancer with programmed death-1and programmed death-ligand 1 inhibitors: A protocol for systematic review and meta-analysis
  af: Li, Honglin, et al.
  Udgivet: (2020)
• Incidence of Immune-Related Adverse Events with Program Death Receptor-1- and Program Death Receptor-1 Ligand-Directed Therapies in Genitourinary Cancers
  af: Maughan, Benjamin L., et al.
  Udgivet: (2017)
• Immune-related adverse events associated with programmed cell death protein-1 and programmed cell death ligand 1 inhibitors for non-small cell lung cancer: a PRISMA systematic review and meta-analysis
  af: Xiaoying Sun, et al.
  Udgivet: (2019-06-01)